Protein C News and Research

RSS

UQ researchers discover a molecule essential for regulating nerve repair

Researchers at The University of Queensland have identified a molecule essential for regulating the repair of injured nerves, which could help people recover from nerve damage.

16 Mar 2022

Scientists discover mechanism that enables Listeria-infected cells to escape immune responses

Some "hypervirulent" strains of Listeria monocytogenes have a greater capacity to infect the central nervous system.

16 Mar 2022

Sneaking large drug-carrying biological molecules into cells using a novel drug delivery system

Scientists from Nanyang Technological University, Singapore have developed a novel method of delivering drugs into human cells using large biological molecules, by first encasing them in a protein-based microdroplet.

16 Mar 2022

In silico identification of novel curcumin derivatives as potential inhibitors against SARS-CoV-2 enzymes

Researchers identified curcumin derivatives as potential inhibitors of SARS-CoV-2 enzymes.

16 Mar 2022

Novel targets to inhibit SARS-CoV-2 variants

A new study identified additional targets on SARS-CoV-2 proteins to prevent the emergence of new SARS-CoV-2 variants of concern.

16 Mar 2022

Convalescent antibodies do not enhance SARS-CoV-2 infection

Researchers investigated whether antibodies enhance severe acute respiratory syndrome coronavirus-2 infection.

16 Mar 2022

High prevalence of COVID-19 in myocardial infarction patients undergoing percutaneous coronary intervention

A team of scientists from Iran has recently estimated the prevalence of coronavirus disease 2019 (COVID-19) in myocardial infarction patients receiving a primary percutaneous coronary intervention. A considerably high prevalence of COVID-19 has been observed among study participants. The study is currently available on the Research Square* Preprint Server.

16 Mar 2022

New insight into SARS-CoV-2 nsp14 protein opens door to new drugs

In a recent research paper currently available on bioRxiv* preprint server, scientists from the University of Oxford in the United Kingdom and the University of Auckland in New Zealand identified several structural specificities of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that may serve as viable starting points for the development and optimization of viral inhibitors against coronavirus disease 2019 (COVID-19) and other future threats.

16 Mar 2022

Ethyl lauroyl arginine hydrochloride (ELAH) nasal spray as potent antiviral against SARS-CoV-2

Researchers evaluate the virucidal effects of ELAH against SARS-CoV-2 and human coronavirus-229E in a nasal spray formulation.

15 Mar 2022

Can cardiac biomarkers determine COVID-19 prognosis?

Researchers review prognostic cardiac biomarkers in COVID-19 patients.

15 Mar 2022

Kidney malfunction associated with cardioembolic stroke

"The foot bone's connected to the ankle bone," goes the schoolyard song, highlighting the ways in which each part of our body can affect other parts of the body.

15 Mar 2022

Acacetin shows potency against SARS-CoV-2 spike protein

Researchers use molecular docking to screen phytocompounds and evaluate their binding affinity with SARS-CoV-2.

15 Mar 2022

Anti-spike IgG dynamics after 2nd BNT162b2 COVID-19 vaccine dose in Japanese health care workers

Researchers investigate the dynamics of anti-spike IgG levels against the SARS-CoV-2 spike protein in Japanese healthcare workers.

15 Mar 2022

Researchers receive grant to find answers to taste loss in COVID patients

Up to 80% of individuals who've had COVID-19 report temporary or lasting changes in their sense of taste, and scientists are working to better understand the biological basis of why, including whether our taste buds are a direct virus target.

15 Mar 2022

Omicron emergence in South Africa associated with increased reinfection risk, analysis finds

The Omicron variant of SARS-CoV-2 evades immunity from prior infection, an analysis of routine surveillance data from South Africa indicates.

15 Mar 2022

Zentalis contributes $1 million to SU2C Catalyst program for research into targeted cancer therapeutics

Stand Up To Cancer and Zentalis Pharmaceuticals, Inc. today announced that Zentalis will contribute $1 million to the SU2C Catalyst program to support research that investigates the use of certain small molecule inhibitors for treating a variety of cancer types.

15 Mar 2022

Orally-active senolytics can boost a key beneficial protein in mice and humans

Mayo Clinic researchers say senolytic drugs can boost a key protein in the body that protects older people against aspects of aging and a range of diseases.

15 Mar 2022

Study takes a new approach to looking at de novo genetic variants in autism

About 1 in 44 children in the U.S. are diagnosed with autism spectrum disorder (ASD) by the age of 8, according to the 2018 Centers for Disease Control and Prevention surveillance. How a child's DNA contributes to the development of ASD has been more of a mystery.

15 Mar 2022

New way to deliver potential HIV vaccine using mRNA technology

Using mRNA technology like that in the COVID-19 vaccines, researchers have demonstrated a successful way to deliver a potential HIV vaccine, researchers at Duke Human Vaccine Institute report.

15 Mar 2022

Skin biopsy can aid in early identification and differential diagnosis of Parkinson's disease

The diagnosis of Parkinson's disease (PD) is currently based on consensus clinical criteria. A novel study reported in the Journal of Parkinson's Disease has found that the presence of neuronal deposits of the biomarker phosphorylated alpha-synuclein (p-syn) in the brain and the skin of patients with PD distinguishes them from individuals with symptoms of parkinsonism due to the accumulation of another protein, tau.

15 Mar 2022

Protein C News and Research

UQ researchers discover a molecule essential for regulating nerve repair

Scientists discover mechanism that enables Listeria-infected cells to escape immune responses

Sneaking large drug-carrying biological molecules into cells using a novel drug delivery system

In silico identification of novel curcumin derivatives as potential inhibitors against SARS-CoV-2 enzymes

Novel targets to inhibit SARS-CoV-2 variants

Convalescent antibodies do not enhance SARS-CoV-2 infection

High prevalence of COVID-19 in myocardial infarction patients undergoing percutaneous coronary intervention

New insight into SARS-CoV-2 nsp14 protein opens door to new drugs

Ethyl lauroyl arginine hydrochloride (ELAH) nasal spray as potent antiviral against SARS-CoV-2

Can cardiac biomarkers determine COVID-19 prognosis?

Kidney malfunction associated with cardioembolic stroke

Acacetin shows potency against SARS-CoV-2 spike protein

Anti-spike IgG dynamics after 2nd BNT162b2 COVID-19 vaccine dose in Japanese health care workers

Researchers receive grant to find answers to taste loss in COVID patients

Omicron emergence in South Africa associated with increased reinfection risk, analysis finds

Zentalis contributes $1 million to SU2C Catalyst program for research into targeted cancer therapeutics

Orally-active senolytics can boost a key beneficial protein in mice and humans

Study takes a new approach to looking at de novo genetic variants in autism

New way to deliver potential HIV vaccine using mRNA technology

Skin biopsy can aid in early identification and differential diagnosis of Parkinson's disease

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News